Globus Medical reports Q4 2024 sales of $657 million, projecting 2025 revenue between $2.66 billion and $2.69 billion. Globus Medical, Inc. has announced preliminary unaudited sales results for Q4 ...

AUDUBON, Pa. - Globus Medical , Inc. (NYSE: NYSE:GMED), a prominent musculoskeletal solutions company with a market capitalization of $11.81 billion and an "GREAT" financial health rating according to ...

Globus Medical expects the Nevro acquisition to be accretive to its earnings in the second year of operation. Globus Medical expects to report full financial results for 2024 and provide its updated ...

Globus Medical reported preliminary sales projections for 2024 of $2.52 ... A Nevro special stockholder meeting will be announced to obtain Nevro stockholder approval in connection with the ...

Globus said it anticipates in annual net sales this year to total between $2.8 billion and $2.9 billion. Globus Medical’s financial adviser for the deal is Morgan Stanley & Co. Wyrick Robbins ...

AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) is showcasing its latest advancements in orthopedic technology at the 40th ...

On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year on an as-reported basis; and On January 13, 2025, Nevro announced ...